Label-free Detection Market to witness major growth in coming years

 The growth of Label-free Detection Market is driven by rising prevalence of target diseases and disorders, the availability of funding for life science research and development, effectiveness of label-free technology in drug discovery. Additionally, the technological advancement in label-free detection leading to expanded applications and adoption of label-free detection products.

The report Label-free Detection Market  is projected to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

Key Market Dynamics:

          1 DRIVERS

                   1.1 Technological advancements in label-free detection

                   1.2 Growing academic-industrial partnerships for drug discovery programs

                   1.3 High sensitivity of label-free technologies

           2 RESTRAINTS

                   2.1 High cost of instruments

           3 OPPORTUNITIES

                   3.1 Growing life sciences research in emerging economies

           4 CHALLENGES

                   4.1 Sample complexity and interference

           5 TRENDS

                   5.1 Rising pharmaceutical outsourcing

                   5.2 Increasing applications of label-free electrochemical sensing platforms

 

Market Segmentation: -

By type, the label-free detection market has been further categorized as instruments, consumables, and software & services. The instrument segment held the largest share of the global label-free detection market in 2022.

Based on technology, the global label-free detection market has been segmented into surface plasmon resonance, differential scanning calorimetry, bio-layer interferometry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment held the largest market share in 2022.

Regional Analysis:

The label-free detection market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in label-free technologies, and collaborative initiatives contribute to the growth of the label-free detection market in the North America region.

Recent Developments of Label Free Detection Industry

• In April 2022, Sartorius launched the new Octet SF3, the first SPR system under the Sartorius Octet brand. Octet SF3 is a next-generation SPR instrument that offers robust, high-throughput, low maintenance characterization of biomolecular interactions.
• In February 2021, Creoptix, a subsidiary of Malvern Panalytical, launched WaveRAPID, a new and faster way of measuring kinetics to accelerate drug discovery.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32435593

Top Key Players: -

Key players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), AMETEK, Inc. (US), HORIBA, Ltd. (Japan), Spectris (UK), METTLER TOLEDO International Inc., (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker (US), NanoTemper Technologies GmbH (Germany), Affinité Instruments (Canada), Biosensing Instrument (US), Unchained Labs (US), BioNavis Ltd. (Finland), Carterra, Inc. (US), Nicoya (Canada), BiOptix Analytical LLC (US), Plexera Bioscience (US), XanTec Bioanalytics GmbH (Germany), lino Biotech AG (Switzerland), and KEP Technologies (France).

The label-free detection market is influenced by factors such as advancements in technology, increasing drug discovery efforts, growing investment in life sciences research, and the need for more accurate and direct measurement of biomolecular interactions. 

Microtome Market: Rising prevalence of cancer

Cancer is a complex disease that develops through the multi-stage carcinogenesis process involving multiple pathways. As a result, there are various hurdles associated with cancer diagnosis, prognosis, and therapy. Cancer is the second-leading cause of death worldwide and accounted for 10 million deaths in 2020. Globally, about 1 in 6 deaths occur due to cancer (Source: WHO). In 2020, 19.3 million new cancer cases were reported, and this figure is expected to increase to 30.2 million by 2040. 

The global Microtome Market is expected to reach USD 585 million by 2027 from USD 425 million in 2022, at a CAGR of 6.6% during the forecast period.

The growth of Microtome market is majorly driven by rising prevalence of cancer, growing demand for digital pathology, recommendations for cancer screening, availability of reimbursement. However, Lack of skilled professionals, and availability of refurbished products are some of the challenges for which may hinder the growth of Microtome market.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411

Market Segmentation:

Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.

Regional Analysis:

Based on the North America region, the microtome market is devided into US and cananda. US is expected to dominate the microtome market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is the key factor driving market growth in the US.

Recent Developments:

• In 2021, Diapath S.P.A. (Italy) launched the Dante Embedding System for anatomic pathology laboratories
• In 2020, Diapath S.P.A. (Italy) launched Cristallo, Galileo S2 Pro microtome.

 

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=230495411

Top Key Players:

The major players in the microtome market are Danaher Corporation (US), PHC holdings corporation (Japan), Cardinal Health (US), Boeckeler Instruments, Inc (US), SM Scientific Instruments Pvt. Ltd. (India), Bright Instruments (UK), Sakura Finetek USA, Inc (US), Jinhua Yidi Medical Equipment Co., Ltd (China), Ted Pella, Inc (US), Medimeas (India), SLEE medical GmbH (Germany), Histo-Line Laboratories (Italy), microTec Laborgeräte GmbH (Germany), MEDITE Medical GmbH (Germany), Erma Inc. (Japan)

Empowering Surgeons with Advanced Technology: A Look at Operating Room Integration

 Factors such as growing demand for technologically advanced solutions, rising funding initiatives for improving HCIT infrastructure increase in the number of surgical procedures, , rise on  emphasis on cost control and  improvement in hospitals operations are aiding to the posticve growth of this market. However, interoperability issues the high setup and operational costs, and shortage of skilled surgeons in OR integration is expected to restrain market growth to a certain extent.

The report Operating Room Integration Market is projected to reach USD 3.7 billion by 2028 from USD 2.1 billion in 2023, at a high CAGR of 12.1% during the forecast period

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667

Operating Room Integration Market Dynamics:

Drivers:

·         Rising demand for technologically advanced solutions

·         Growing number of surgical procedures worldwide

·         Rising funding initiatives for the improvement of HCIT infrastructure

·         Increasing emphasis on cost control in hospitals

Opportunities:

·         Growth opportunities in emerging economies

Challenges:

·         Shortage of skilled surgeons in integrated operating rooms

·         Interoperability issues

Market Segmentation: -

The software segment accounted for the largest share, by component in the operating room integration market in 2022. The large share of OR integration software is attributed to reduced surgical times, improved patient safety and improved coordination between healthcare providers.

Based on application, the orthopedic surgery segment is expected to register the highest CAGR during the forecast period. Orthopedic surgery aims to attenuate the pain caused by musculoskeletal conditions such as joint arthritis, fractures, torn ligaments, or herniated discs.

Regional Analysis:

North America held the largest share of the operating room integration market in 2022, followed by Europe and Asia Pacific.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=160774667

Recent Developments

·         In February 2023, KARL STORZ collaborated with Asensu Surgical (US), Through this collaboration, the company developed next-generation equipment and also aimed to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device.

·         In February 2022, Stryker acquired Vocera Communications (US). This acquisition offers Stryker's Medical division an innovative portfolio that boosts the company's Advanced Digital Healthcare services and advance Stryker's focus on preventing adverse occurrences throughout the continuum of care.

·         In December 2022, Olympus Corporation (US) collaborated with Sony Corporation (Japan) for the development of a surgical endoscopy system with surgical visualization features such as 4K, 3D, infrared (IR) imaging, and NBI (Narrow Band Imaging).

Top Key Players:

Stryker Corporation (US), STERIS Plc (US), Karl Storz SE & Co. KG (Germany), Olympus Corporation (Japan), and Getinge AB (Sweden) are the major players in this market. These companies are majorly focusing on strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market.

The operating room integration market has grown as healthcare facilities seek to enhance surgical capabilities, improve patient care, and stay updated with the latest technologies. However, the extent of adoption can vary based on factors such as healthcare infrastructure, budget constraints, and regulatory environment in different regions. The market continues to evolve with advancements in technology and a focus on patient outcomes.

 

Respiratory Diagnostics Market - Exclusive Report by MarketsandMarkets™

 As per the recently published report by MarketsandMarket™, The report "Respiratory Diagnostics Market by Product & Services (Devices, Reagents, Software), Test (PFT, Peak Flow, Spirometry), OSA, Imaging (X-ray, CT, MRI, PET), Molecular (PCR, DNA Sequencing), Indication (Lung Cancer, Asthma, COPD, TB) - Global Forecast to 2029", is expected to reach USD 8.2 billion by 2029 from USD 5.6 billion in 2023, at a CAGR of 6.6%, during the forecast period.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459
 
Browse

• 83       Market Data Tables
• 45       Figures
• 146     Pages and in-depth TOC on "Respiratory Diagnostics Market - Global Forecast to 2029”

Some of the prominent key players are:

• Koninklijke Philips N.V. (Netherlands),
• BD (US),
• Abbott (US),
• Thermo Fisher Scientific Inc. (US),
• GE HealthCare (US),
• Bio-Rad Laboratories, Inc. (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Respiratory Diagnostics Market.

Get Discount on this Report: https://www.marketsandmarkets.com/discountreports.asp?id=163390459

• The growing trend towards point-of-care testing (POCT) represents a paradigm shift in healthcare, significantly contributing to the growth of the instruments and devices segment. Portable respiratory diagnostic instruments, such as handheld spirometers, peak flow meters, and portable imaging devices, enable real-time assessment of lung function and conditions.
• The escalating prevalence of respiratory disorders, particularly chronic obstructive pulmonary disease (COPD) and asthma, underscores the critical role of mechanical tests in assessing lung function. Mechanical tests, such as spirometry and peak flow tests, play a fundamental role in evaluating lung function by measuring parameters like airflow, lung volume, and capacity.
• Personalized asthma care is increasingly reliant on sophisticated diagnostic tools that consider individual patient profiles. Advanced diagnostics, such as molecular testing and biomarker analysis, enable healthcare professionals to delve into the specific genetic and molecular factors contributing to a patient's asthma.
• Hospitals and clinics are increasingly integrating respiratory diagnostics into routine care protocols. The seamless integration of respiratory diagnostics within hospitals and clinics ensures that diagnostic services are readily accessible to a broad spectrum of patients seeking routine or specialized care.
• In 2022, North America held the largest market share for respiratory diagnostics market. The growing awareness of the significance of early detection and effective management of respiratory diseases has emerged as a significant factor propelling the utilization of respiratory diagnostics products and services in North America.

Growth in this market is largely driven by the growth in the large patient population suffering from pulmonary diseases, increase in pre-term deliveries, rise in adults being exposed to poor air quality index environment, increased smoking of tobacco, increased cases of passive smoking due to exposure to harmful smoke inhalations, rise in dust and allergies associated with it leading to asthma and COPD, rising R&D expenditure by leaders in this market, increased trend of smoking in women more than men, and massive rise in underlying lung diseases, and continuous exposre to indoor or outdoor dust, making it prone to infections, leading the market growth.

Metagenomic Sequencing Market: Continuous technological innovations in NGS platforms

 The Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.

The global metagenomic sequencing market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $4.5 billion in 2028, growing at a CAGR of 17.5% from 2023 to 2028.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643

Key Driving growth factors:

1 DRIVERS

                   1.1 Continuous technological innovations in NGS platforms

                               1.1.1 Ion Torrent Genexus Dx Integrated Sequencer

                               1.1.2 iSeq 100 System

                               1.1.3 Ion GeneStudio S5

                   1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects

                   1.3 Declining cost of genome sequencing

                                 

                   1.4 Significant applications of metagenomics in various fields

 

Market Segmentation:

Among the products & service, the metagenomic sequencing market is segmented reagents & consumables, instruments, sequencing services and analysis & data interpretation solutions. In 2023, the reagents and consumables segment accounted for the largest share of the metagenomic sequencing market by product & service.

Among the applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications.

Regional Analysis.

Geographically, the metagenomic sequencing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The metagenomic sequencing market was dominated by North America in 2022 and this dominance is anticipated to continue throughout the forecast period between 2023 and 2028.

Recent Developments:

• In September 2022, Illumina, Inc. (US) launched the NovaSeq X series production-scale sequencers, which are capable of generating more than 20,000 whole genomes per year (which is 2.5 times the throughput of prior sequencers from Illumina).
• In September 2021, Thermo Fisher Scientific, Inc. (US) and AstraZeneca(UK) co-developed an NGS-based companion diagnostic. The collaboration was focused on commercializing NGS-based diagnostics in Russia.  

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=60408643

Top Key Players:

The market for metagenomic sequencing is consolidated, with key players strategizing to capture the market. Prominent players in the metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK) among others.

The Metagenomic Sequencing Market is a dynamic and rapidly evolving industry with significant implications for various sectors, including healthcare, agriculture, environmental science, and biotechnology. Advances in technology and increased awareness of the importance of microbiome research are expected to continue driving growth in this market.

 

Revolutionizing Surgery: Exploring the Global Surgical Robots Market

 The surgical robots market refers to the industry and market segment focused on robotic systems designed for use in surgical procedures. Surgical robots are advanced medical devices that assist surgeons in performing complex surgical procedures with enhanced precision, control, and flexibility.

The report Surgical Robots Market is projected to reach USD 18.4 billion by 2027 from an estimated USD 8.5 billion in 2022, at a CAGR of 16.6% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Surgical Robots Market Dynamics:

Drivers:

1. Advantages of robotic-assisted surgery
2. Technological advancements
3. Improving reimbursement scenario
4. Increasing adoption of surgical robots
5. Increase in funding for medical robot research

Opportunities:

1. Increasing penetration of surgical robots in ASCs

Market Segmentation: -

·         By product & service, the surgical robots market has been segmented into robotic systems, instruments & accessories, and services. In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.

·         By robotic systems, the surgical robots market has been segmented into laparoscopy robotic systems, orthopedic robotic systems, neurosurgical robotic systems, and other systems.

·         By application, the surgical robots market has been segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment is projected to register the highest growth during the forecast period.

·         Based on end users, the market has been segmented into hospitals & clinics and ambulatory surgery centers. In 2021, the hospitals & clinics accounted for the largest share of the market.

Regional Analysis:

Europe is another prominent region in the surgical robots market. Countries such as Germany, the United Kingdom, France, and Italy have been key players in this market. The region has a well-established healthcare system, high awareness about robotic technologies, and favorable reimbursement policies, which have contributed to the growth of the market.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Recent Developments:

• In 2022, BGS Beta-Gamma-Service GmbH & Co. KG expanded its laboratory in Wiehl to meet the increased need for sterilization services in the sectors of biotechnology, medicine, and diagnostics for radiation cross-linking.
• In 2022, Sterigenics expanded its electron beam facility located in Columbia city, Indiana. This facility provides mission-critical E-beam sterilization services to help ensure the safety of medical devices and drug products.
• In 2021, STERIS acquired Cantel, which is a provider of infection prevention services, and this acquisition will strengthen the STERIS leadership in infection prevention by bringing together two complementary businesses.

Top Key Players:-

Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc. (UK) are key players in the surgical robots market.

It's important to note that the surgical robots market is dynamic and evolving, with ongoing research and development leading to the introduction of new technologies and applications. Regional market dynamics can vary based on factors such as healthcare infrastructure, reimbursement policies, and regulatory environment.

 

 

Operating Room Integration Market worth $3.7 billion by 2028 - Exclusive Report by MarketsandMarkets™

 Factors such as growing demand for technologically advanced solutions, rising funding initiatives for improving HCIT infrastructure increase in the number of surgical procedures, , rise on  emphasis on cost control and  improvement in hospitals operations are aiding to the posticve growth of this market. However, interoperability issues the high setup and operational costs, and shortage of skilled surgeons in OR integration is expected to restrain market growth to a certain extent.

The report Operating Room Integration Market is projected to reach USD 3.7 billion by 2028 from USD 2.1 billion in 2023, at a high CAGR of 12.1% during the forecast period

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667

Operating Room Integration Market Dynamics:

Drivers:

·         Rising demand for technologically advanced solutions

·         Growing number of surgical procedures worldwide

·         Rising funding initiatives for the improvement of HCIT infrastructure

·         Increasing emphasis on cost control in hospitals

Opportunities:

·         Growth opportunities in emerging economies

Challenges:

·         Shortage of skilled surgeons in integrated operating rooms

·         Interoperability issues

Market Segmentation: -

The software segment accounted for the largest share, by component in the operating room integration market in 2022. The large share of OR integration software is attributed to reduced surgical times, improved patient safety and improved coordination between healthcare providers.

Based on application, the orthopedic surgery segment is expected to register the highest CAGR during the forecast period. Orthopedic surgery aims to attenuate the pain caused by musculoskeletal conditions such as joint arthritis, fractures, torn ligaments, or herniated discs.

Regional Analysis:

North America held the largest share of the operating room integration market in 2022, followed by Europe and Asia Pacific.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=160774667

Recent Developments

·         In February 2023, KARL STORZ collaborated with Asensu Surgical (US), Through this collaboration, the company developed next-generation equipment and also aimed to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device.

·         In February 2022, Stryker acquired Vocera Communications (US). This acquisition offers Stryker's Medical division an innovative portfolio that boosts the company's Advanced Digital Healthcare services and advance Stryker's focus on preventing adverse occurrences throughout the continuum of care.

·         In December 2022, Olympus Corporation (US) collaborated with Sony Corporation (Japan) for the development of a surgical endoscopy system with surgical visualization features such as 4K, 3D, infrared (IR) imaging, and NBI (Narrow Band Imaging).

Top Key Players:

Stryker Corporation (US), STERIS Plc (US), Karl Storz SE & Co. KG (Germany), Olympus Corporation (Japan), and Getinge AB (Sweden) are the major players in this market. These companies are majorly focusing on strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market.

The operating room integration market has grown as healthcare facilities seek to enhance surgical capabilities, improve patient care, and stay updated with the latest technologies. However, the extent of adoption can vary based on factors such as healthcare infrastructure, budget constraints, and regulatory environment in different regions. The market continues to evolve with advancements in technology and a focus on patient outcomes.